VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1534328
Sex: F
Age:
State: NC

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Extra tired; When started working felt extremely disoriented; Dizzy; Foggy; Feelings of super anxiety (adrenaline continued to take over); Felt a level of irritability; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took guaifenesin (MUCINEX) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 10:00, the patient woke up morning with extra tired, when started working felt extremely disoriented, dizzy, foggy. It only got worsened throughout the day, feelings of super anxiety from what she could describe as adrenaline continued to take over, also felt a level of irritability she had never felt in her life. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events extra tired, when started working felt extremely disoriented, dizzy, foggy, feelings of super anxiety (adrenaline continued to take over), and felt a level of irritability were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534329
Sex: F
Age:
State: NY

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: foot swelled up intensely; this foot swelled up intensely with lots of pain.; pain shooting up in leg; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN,) via an unspecified route of administration on 05Apr2021 at 14:30 (at the age of 40-year-old), as a single dose for COVID-19 immunisation. Medical history included cadaver bone and a 3-titanium screw in the right foot from a surgery 6 years ago and the patient had a history of allergy to dairy. Concomitant medications included birth control from an unknown date for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 16:00, the patient experienced few hours after the vaccine foot swelled up intensely with lots of pain and had been swollen and painful ever since the injection with pain shooting up the leg. On 22Mar2021, the patient underwent COVID-19 (nasal swab) test and result was found to be negative. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events foot swelled up intensely with lots of pain and pain shooting in leg was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1534330
Sex: M
Age:
State: FL

Vax Date: 04/01/2021
Onset Date: 04/04/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Bad diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 01Apr2021 at 01:45 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021 at 23:00, the patient experienced bad diarrhea for 4 days. No therapeutic measures were taken for the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event bad diarrhea was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1534331
Sex: F
Age:
State: AL

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Neck pain; Difficulty breathing; Fast heartbeat; Headache; Fever; Feeling unwell; Injection site swelling; Injection site redness; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 10:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had history of known allergies to penicillin (MANUFACTURER UNKNOWN). Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 11:30, the patient experienced difficulty breathing, fast heartbeat, headache, neck pain, fever, feeling unwell, nausea, injection site swelling and redness. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of difficulty breathing, fast heartbeat, headache, neck pain, fever, feeling unwell, nausea, injection site swelling and redness were recovered on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534332
Sex: F
Age:
State: NC

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Swollen at injection site; red at injection site; itchy welt at injection site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Er8737) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included dermatographia and sulfonamide allergy. Concomitant medications included evolcumab (REPATHA injection), rosuvastatin calcium (CRESTOR 20mg) for unknown indication from unknown date within two weeks of vaccine. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) via an unspecified route of administration in the left arm on 20Mar2021 at 11:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 09Apr2021 at 08:00, the patient experienced swollen, red and itchy welt at injection site. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swollen, red and itchy welt was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: REPATHA; CRESTOR

Current Illness:

ID: 1534333
Sex: M
Age:
State: NC

Vax Date: 03/18/2021
Onset Date: 03/25/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 18Mar2021 at 11:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and did not take any concomitant medication. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021, the patient experienced tinnitus. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as the result of reported event tinnitus. The clinical outcome of the event tinnitus was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534334
Sex: F
Age:
State: NC

Vax Date: 04/08/2021
Onset Date: 04/10/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Swollen lymph nodes under left arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient had previous allergy to codeine. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 20Mar2021 at 11:45 as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 08:00, the patient experienced swollen lymph nodes under left arm. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534335
Sex: F
Age:
State: WA

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Pain at injection site; abnormal dehydration; nausea; vomiting; fever of 100.8; headaches; muscle aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021(at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included mild asthma. Concomitant medications included intrauterine contraceptive device (MANUFACTURER UNKNOWN) implant from an unknown date and for an unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 14:00, the patient experienced pain at injection site(vaccination site pain), abnormal dehydration, nausea, vomiting, fever of 100.8, headaches, muscle aches and chills. The patient did not receive any treatment for the reported events. On an unknown date, the patient underwent lab tests which included body temperature and the result was 100.8 (unit unknown). The clinical outcome of the events pain at injection site, abnormal dehydration, nausea, vomiting, fever of 100.8, headaches, muscle aches and chills were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: INTRAUTERINE CONTRACEPTIVE DEVICE

Current Illness:

ID: 1534336
Sex: F
Age:
State: NJ

Vax Date: 03/27/2021
Onset Date: 03/29/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: right hand shoulder had inflammation; was unable to move my hand; extreme pain with any movement of my hand/horrible pain while moving my arm; stiffness and horrible pain while moving my arm.; Very tiny rash on my right risk; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 14:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, high cholesterol, asthma, neck and shoulder pain and environmental allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN), all for unknown indications on unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 11:00, Monday morning, the patient's right hand shoulder had inflammation and she was unable to move her hand. There was an extreme pain with any movement of hand. The patient also reported that she had a sore neck (right side) and sore shoulder (right side) for weeks before the vaccine. She slept on her right side Sunday night and Monday morning woke up with this stiffness and horrible pain while moving her arm. She was much better after physical therapy on Tuesday 30Mar2021. The patient went to orthopedic surgeon on 01Apr2021 (thu) and doctor gave a cortisone shot on her right hand. She was much better now with her right shoulder and didn't had any pain while moving it. She also had a "very tiny rash on my right risk" which was gone now. The patient reported that she hopes she can get her scheduled second shot on 17Apr2021. She also reported that she doesn't know if the shot triggered this inflammation and pain. Events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events and included treatment with physical therapy on Tuesday, 30Mar2021 and Cortisone shot by Orthopedic Surgeon on 01Apr2021. The clinical outcome of the events right hand shoulder had inflammation, unable to move her hand, extreme pain with any movement of hand, stiffness and horrible pain while moving her arm and very tiny rash on right risk was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; PANTOPRAZOLE; SIMVASTATIN; LISINOPRIL

Current Illness:

ID: 1534337
Sex: F
Age:
State: NJ

Vax Date: 03/22/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: shingles on my face; Shingles on my face and in my mouth; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 22Mar2021 at 17:00 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to penicillin. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203), via an unspecified route of administration in the left arm on 01Mar2021 at 17:00 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced "shingles on my face and in my mouth". The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events shingles on my face and in my mouth which included treatment with anti-viral drug from an unknown date. The clinical outcome of the events shingles on my face and in my mouth were not resolved at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE

Current Illness:

ID: 1534338
Sex: F
Age:
State: IN

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Headache - moderate; Nausea- moderate; Injection site soreness; Fever-severe; Chills severe; Muscle aches- severe; Joint aches- severe; Severe sweating; Thirst drenched; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 09Apr2021 at 14:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient had allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA), buspirone (MANUFACTURER UNKNOWN) and ethinylestradiol, norethisterone (NOTREL) all were from an unknown date for an unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 19Mar2021 at 15:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 18:00, within 4 hours after the vaccination, the patient experienced moderate headache, moderate nausea and injection site soreness. On 09Apr2021 at 01:00, within 11 hours after the vaccination, the patient experienced severe fever, chills, muscle aches, joint aches, continued moderate headache and nausea, severe sweating and thirst drenched. It was reported that the patient's pajamas in sweat 3X sheets and pillow sweated out. At 24 hours post-dose, fever was mild to moderate, chills mild to moderate, mild headache and nausea, severe muscle and joint aches and fatigue. Therapeutic measures were taken as a result of the events included treatment with 1000 mg Tylenol every 6 hours from 09Apr2021 at 23:00. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, nausea, injection site soreness, severe fever, chills, muscle aches, joint aches, severe sweating and thirst drenched were recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: CYMBALTA; BUSPIRONE; BREVICON

Current Illness:

ID: 1534339
Sex: F
Age:
State: FL

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Sore arm; Mild Headache; This is a spontaneous report from a contactable nurse. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0 151) via an unspecified route of administration in the left arm on 09Apr2021 at 12:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any medication within two weeks of vaccination. The patient previously took Demerol, Darvocet (Darvicette), Morphine, Vancomycin, Reglan and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced sore arm and mild headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore arm and mild headache was resolved on 10Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534340
Sex: M
Age:
State:

Vax Date: 04/01/2021
Onset Date: 04/10/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Headache; nausea; This is a spontaneous report from a non-contactable consumer, the patient. A male patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 11:45 as a single dose for COVID-19 immunisation. Medical history included hypertension. The patient had no known allergies to medications, food, or other products. Concomitant medication was reported as yes (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 09:00, the patient experienced headache and nausea. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache and nausea were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1534341
Sex: F
Age:
State: NC

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Fever since the day after the vaccination (6 days); This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Apr2021 at 14:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced fever since the day after the vaccination (6 days). The patient did not receive any treatment for the event. On 10Apr2021, the patient underwent a nasal swab test for COVID-19 and the result was Negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever since the day after the vaccination (6 days) was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534342
Sex: F
Age:
State: NC

Vax Date: 04/07/2021
Onset Date: 04/10/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Golf ball size swelling to left of the right antecubital fossa; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7533) via an unspecified route of administration in the right arm on 07Apr2021 at 16:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, atrial fibrillation, overweight, smoker and allergy to PC (penicillin). Concomitant medications included naltrexone hydrochloride, bupropion hydrochloride (CONTRAVE), acetylsalicylic acid (ASA) and multivitamins (MANUFACTURER UNKNOWN) for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 the patient experienced golf ball size swelling to left of the right antecubital fossa. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event swelling to left of the right antecubital fossa was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: CONTRAVE; ASA

Current Illness:

ID: 1534343
Sex: F
Age:
State: FL

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Chills; terrible migraine; achey entire body; couldn't sleep; arm tender; clenched jaw for several hours; lack of energy; couldn't relax; no appetite; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0151), via an unspecified route of administration in the left arm on 09Apr2021 at 10:00 (at the age of 34 years old) as single dose for COVID-19 immunisation. The patient had no reported medical history. Concomitant medications included prenatal & OTC allergy meds from an unknown date and for unknown indication. The patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6208), via an unspecified route of administration in the left arm on 19MAr2021 at 11:15 as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. On 09Apr2021 at 21:00, patient experienced chills, terrible migraine, ache entire body, couldn't sleep, arm tender, clenched jaw for several hours couldn't relax, lack of energy and no appetite. The patient did not receive any treatment for the reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event chills, terrible migraine, ache entire body, couldn't sleep, arm tender, clenched jaw for several hours couldn't relax, lack of energy and no appetite were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534344
Sex: M
Age:
State: GA

Vax Date: 03/01/2021
Onset Date: 03/16/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: About 15-16 days after the vaccine, I developed a severe case of shingles.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263) via an unspecified route of administration in the left arm on 01Mar2021 at 15:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to food, medicine or other products. Concomitant medications taken within two weeks prior to vaccination included bupropion hydrochloride (manufacturer: WELLBUTRIN XL), losartan (MANUFACTURER UNKNOWN), quetiapine fumarate (manufacturer: SEROQUEL), lurasidone hydrochloride (manufacturer: LATUDA) and alprazolam (manufacturer: XANAX) all from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, about 15-16 days after the vaccine, the patient developed a severe case of shingles. The event resulted in doctor or other healthcare professional office/clinic visit. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of shingles and included treatment with Antiviral medication, steroid, pain medication. The clinical outcome of the event about 15-16 days after the vaccine, the patient developed a severe case of shingles was resolved with sequelae on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN XL; LOSARTAN; SEROQUEL; LATUDA; XANAX

Current Illness:

ID: 1534345
Sex: F
Age:
State: TX

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Shooting pains in legs and arms; Restless legs; Severe dry mouth; constant thirst; Chills; Fever; Headache; Vertigo; Fog feeling; Almost felt like a bad hangover mixed with foodpoisoning; Almost felt like a bad hangover mixed with foodpoisoning; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8737) via an unspecified route of administration in the left arm on 01Apr2021 at 09:15 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergies to medications, food, or other products. The patient received nature made daily vitamin for women within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 19:00, the patient experienced shooting pains in legs and arms, restless legs, severe dry mouth, constant thirst, chills, fever, headache, vertigo, in a fog feeling and almost felt like a bad hangover mixed with food poisoning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events shooting pains in legs and arms, restless legs, severe dry mouth, constant thirst, chills, fever, headache, vertigo, fog feeling, almost felt like a bad hangover mixed with food poisoning were recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1534346
Sex: F
Age:
State: ID

Vax Date: 04/05/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: flu like symptoms; Headache; fever; Joint pain; chills; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced flu like symptoms, headache, chills fever and joint pain. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events flu like symptoms, headache, chills fever and joint pain was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534347
Sex: F
Age:
State: FL

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Pins and needles; numbness in left side of face; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the arm left on 09Apr2021 at 10:15 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient's concomitant medications included mirabegron (MYRBETRIQ), ethinylestradiol, norethisterone (PIRMELLA) and fluconazole (DIFLUCAN) from unknown start date for unknown indications. The patient's medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 20:00, the patient experienced pins and needles and numbness in left side of face. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the events pins and needles and numbness in left side of face was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: MYRBETRIQ; PIRMELLA; DIFLUCAN

Current Illness:

ID: 1534348
Sex: F
Age:
State: IL

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Severe, stabbing and piercing feeling on the left upper side of my right breast.; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 02Apr2021 at 08:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal). The patient had no known allergies. Concomitant medications included famotidine once a day (MANUFACTURER UNKNOWN), cultrelle (MANUFACTURER UNKNOWN), flaxs (MANUFACTURER UNKNOWN) and calcium carbonate, colecalciferol (CALTRATE) from unknown date for unknown indication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 10:00, the patient experienced severe, stabbing and piercing feeling on the left upper side of her right breast. After that feeling, there was pain that lasted for 4 days. As the days passed on, the pain had diminished. The pain had scared the patient that she thought of going to the ER. No therapeutic measures were taken as a result of the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe, stabbing and piercing feeling on the left upper side of her right breast was recovered on 07Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: FAMOTIDINE; Caltrate

Current Illness:

ID: 1534349
Sex: F
Age:
State: TX

Vax Date: 03/08/2021
Onset Date:
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: I had regular bloodwork done on February 18th. I had an appt on the first of April to get my results back. My platelets had dropped to 134,000 and they are normally over 150,000; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 08Mar2021 at 13:45 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. The patient received unspecified concomitant medications and also received shingrix (MANUFACTURER UNKNOWN) on 20Feb2021 in left arm for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received other vaccine within four weeks prior to the vaccination. On 18Feb, the patient had regular bloodwork done. She had an appt on the first of April to get her results back. Her platelets had dropped to 134,000 and they were normally over 150,000. On an unknown date, the patient underwent platelet count and the result was her platelets had dropped to 134,000 and they are normally over 150,000. Therapeutic measures were not taken as a result of the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event platelet count decreased was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534350
Sex: F
Age:
State: PA

Vax Date: 04/05/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Sore lymph node on left collarbone; Swollen lymph node on left collarbone; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 14:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Patient had no known allergies to medications, food or other products. Concomitant medications included lisinopril dihydrate (LISINOPRIL), venlafaxine hydrochloride (EFFEXOR), norgestimate (ORTHO CYCLEN) for unknown indication, from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 the patient experienced sore lymph node on left collarbone and swollen lymph node on left collarbone. No therapeutic measures were not taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore lymph node and swollen lymph node on left collarbone was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; EFFEXOR; ORTHO CYCLEN

Current Illness:

ID: 1534351
Sex: F
Age:
State: FL

Vax Date: 04/03/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: a few circular, shiny, raised patches of skin on the injected arm; whole body itching and My fingertips itching; a few circular, shiny, raised patches of skin on the injected arm; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 03Apr2021 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included year round environmental allergy and asthma. The patient received unspecified medication within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 13Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021, after the third day of the second dose, the patient developed a few circular, shiny, raised patches of skin on the injected arm and whole body itching and fingertips were itching. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events which included treatment with benadryl. The clinical outcome of the event few circular, shiny, raised patches of skin on the injected arm and whole body itching and fingertips were itching was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534352
Sex: M
Age:
State: MD

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Had a temperature the whole day; Feeling fatigue; Laziness; Pain started in the left arm; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) via an unspecified route of administration in the left arm on 09Apr2021 at 13:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any other medications in two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 18:00, the patient experienced pain started in the left arm. On 09Apr2021 at 22:00, the patient experienced fatigue/laziness. On 10Apr2021 the next day, the patient experienced temperature the whole day. Therapeutic measures were taken as a result of the event fever which included treatment with Dolo-650 mg tablet. The clinical outcome of the events pain started in the left arm, fatigue, laziness and temperature was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534353
Sex: F
Age:
State: MD

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Strong metallic taste in mouth 5 minutes after dose; Strong headache about 20 minutes after dose; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 25Mar2021, at 15:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic, obesity and high blood pressure. The patient had no allergies to medications, food or other products. Concomitant medications included montelukast sodium (SINGULAIR), sertraline hydrochloride (ZOLOFT) and irbesartan (MANUFACTURER UNKNOWN) all for unknown indicatio, from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25Mar2021 at 15:15, the patient experienced strong metallic taste in mouth 5 minutes after dose and strong headache about 20 minutes after dose. No therapeutic measures were taken as a result of reported adverse events. The clinical outcome of the events strong metallic taste in mouth 5 minutes after dose and strong headache about 20 minutes after dose was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SINGULAIR; ZOLOFT; IRBESARTAN

Current Illness:

ID: 1534354
Sex: F
Age:
State: FL

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Painful cramps; started my menstrual cycle - 2 weeks early. I am on birth control and have not had a period out of schedule since I started on the pill in my 20's.; extremely heavy with painful cramps -which I have not had since starting on the pill in my 20's; Left arm from shoulder down to elbow was very painful; Left arm from shoulder down to elbow was very painful; Left arm from shoulder down to elbow was very painful and felt very heavy for a few days; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534), via an unspecified route of administration in the left arm on 07Apr2021 at 16:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure, seasonal allergy and food allergy (lactose intolerant). The patient receives unspecified medications within two weeks of vaccination. The patient previously took codeine, percocet and neosporin; all on unknown dates for unspecified indications and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in the left arm on 18Mar2021 at 14:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced left arm from shoulder down to elbow was very painful, felt very heavy for a few days. The patient had to keep ice pack on it all day/night. On 08Apr2021, day after second dose, the patient started her menstrual cycle- 2 weeks early, the patient was on birth control and have not had a period out of the schedule since she started on the pill in her 20's. It has also been extremely heavy with painful cramps-which she has not had since starting on the pill in her 20's. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events left arm from shoulder down to elbow was very painful, felt very heavy for a few days, started her menstrual cycle- 2 weeks early, it has also been extremely heavy with painful cramps were not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534355
Sex: F
Age:
State: MN

Vax Date: 04/01/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Swelling/redness at the injection site; Swelling/redness at the injection site.Did not have any redness for the first week. It was about an inch wide and has since gotten to be about twoinches.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the right arm on 01Apr2021 at 12:15 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food or other products. Concomitant medications included somatropin (NORDITROPINE) from unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, a week later, the patient noticed swelling/redness at the injection site. The patient did not have any redness for the first week. It was about an inch wide and has since gotten to be about two inches. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events swelling/redness at the injection site, did not have any redness for the first week, it was about an inch wide and has since gotten to be about two inches were unknown at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: NORDITROPINE

Current Illness:

ID: 1534356
Sex: F
Age:
State: NY

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0162) via an unspecified route of administration in the arm left on 10Apr2021 at 08:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Pregnant at the time of vaccination was reported as unknown. Concomitant medications included estradiol (ESTRADIOLO), progesterone (MANUFACTURER UNKNOWN) and chlorpropamide (CHLOMIDE) for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727) via an unspecified route of administration in the arm left on 20Mar2021 at 08:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 22:30 the patient experienced Dizziness. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event Dizziness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ESTRADIOLO; PROGESTERONE; CHLOMIDE

Current Illness: Penicillin allergy (Known allergies: Penicillin)

ID: 1534357
Sex: F
Age:
State: CA

Vax Date: 04/05/2021
Onset Date: 04/10/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: I have been tired; dizzy on and off since I got my vaccine, 5 days ago; Today I realized I got my period a full week early.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 05Apr2021 at 14:00(at the age of 37-year-old) as a single dose for COVID-19immunisation. Medical history included asthma, gluten intolerance and sulfonamide allergy. The patient received unspecified medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG199) via an unspecified route of administration in the left arm on 15Mar2021 at 14:00(at the age of 36-year-old) as a single dose for COVID-19immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 10Apr2021 at 09:30 the patient experienced that she had been tired (fatigue) and dizzy on and off since she got her vaccine, 5 days ago. She realized she got her period a full week early (menstruation abnormal) .Therapeutic measures were taken as a result of the adverse events and included treatment with acetaminophen (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN). On 31Mar2021, the patient underwent Nasal Swab test for COVID-19 and the result was Negative. On 03Apr2021, the patient underwent Nasal Swab test for COVID-19 and the result was Negative. The clinical outcome of the events she had been tired(fatigue) and dizzy on and off since she got her vaccine, 5 days ago, she realized that she got her period a full week early (menstruation abnormal) were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534358
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 02/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: No period after 64 days and counting,; no ovulation; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included alprazolam (XANAX) from unknown date and for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Feb2021 the patient experienced no period after 64 days and counting and no ovulation either. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. The clinical outcome of the events no period after 64 days and counting and no ovulation either were not resolved at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: XANAX

Current Illness:

ID: 1534359
Sex: M
Age:
State: IL

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Episodic left arm pit pain; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265) via an unspecified route of administration in the left arm on 07Apr2021 at 17:15 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. Medical history included lung lobectomy in 2008 to address pulmonary sequestration. The patient did not take any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the left arm on 17Mar2021 at 17:15 (at the age of 53-year-old), as a single dose for COVID-19 immunisation and took Clarithromycin, Amoxicillin and Clindamycin; all on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. On 09Apr2021 at 02:00, the patient experienced episodic left arm pit pain. The patient did not receive any treatment for the reported event. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event episodic left arm pit pain was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534360
Sex: F
Age:
State: TN

Vax Date: 03/26/2021
Onset Date: 04/06/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Dizziness; Headache; Bleeding 6 days later; Another period; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, chronic allergies, asthma, premenstrual syndrome (PMS) and ovulation pain. The patient had no known allergies. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), cetirizine hydrochloride (ZYRTEC), DIM supplement and prenatal vitamins from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 10:00, the patient experienced dizziness and headache, was not sure if the events were the result of the vaccine until the patient was supposed to ovulate the 11 days later (the patient felt ovulation and always cramp with ovulation), the patient started with another period and was still bleeding 6 days later while the patient has had 4 day cycles the entirety of 24 years of menstruating. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events dizziness, headache, cramp with ovulation, bleeding 6 days later and another period was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALLEGRA; Zyrtec

Current Illness:

ID: 1534361
Sex: F
Age:
State: TX

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: her nose and tremendous amount of blood came out,; pregnant; This is a spontaneous report from a contactable consumer, the patient. This is a maternal report. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTCH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration on 07Apr2021 as dose 1, single for covid-19 immunisation. Medical history included was None. The patient concomitant medications were not reported. Patient was 39 weeks pregnant and got the first dose of the vaccine 07Apr2021. Patient said she blew her nose and a tremendous amount of blood came out, asking if that was normal. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1534362
Sex: F
Age:
State: NC

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Started with chills; Tiredness; 100 degree fever; Headache; Faster heartbeat; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er 8737), via an unspecified route of administration in the left arm on 08Apr2021 at 17:00 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included extra heartbeat, COVID-19 and sulfonamide allergy. Concomitant medications included Alive multi-vit, 2 calcium pills (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and biotin (MANUFACTURER UNKNOWN); all from an unknown date for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 15:00, next afternoon the patient experienced started with chills, tiredness and then 100-degree fever with headache, faster heartbeat. The patient took an ibuprofen & slept most of the afternoon/evening and rest of night, and felt better next day. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 09Apr2021 at 15:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100-degree. The clinical outcome of the events chills, tiredness and then 100-degree fever with headache, faster heartbeat were recovering at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: CALCIUM; Zyrtec; BIOTIN

Current Illness:

ID: 1534363
Sex: F
Age:
State: TX

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: slow labored breathing; rapid heartbeat; blurry vision; swollen lymph nodes; fever; chills; extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the right arm on 05Apr2021 at 11:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, asthma, attention deficit hyperactivity disorder (ADHD) and pollen allergy. Concomitant medications included amfetamine aspartate; amfetamine sulfate; dexamfetamine saccharate; dexamfetamine sulfate (ADDERALL) for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the right arm on 12Mar2021 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 12:30, the patient experienced extreme fatigue, chills, fever, slow labored breathing, rapid heartbeat, swollen lymph nodes and blurry vision. Therapeutic measures were taken as a result of adverse events and included treatment with ibuprofen on day two and three of adverse effects. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 05Apr2021, the patient underwent nasal swab test and the result was negative. The clinical outcome of the event extreme fatigue, chills, fever, slow labored breathing, rapid heartbeat, swollen lymph nodes and blurry vision was recovered with lasting effects on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL

Current Illness:

ID: 1534364
Sex: F
Age:
State: NY

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: short of breath (had to rest to catch my breath); catching cough; feeling exhausted; Intermittent weakness; feeling out of it; pain at injection site to shoulder up to left side of neck; pain at injection site to shoulder up to left side of neck; pain at injection site to shoulder up to left side of neck; experienced GI symptoms started bloating and cramping led to profuse water diarrhea; experienced GI symptoms started bloating and cramping led to profuse water diarrhea; water diarrhea started in the evening and stopped around 8pm; Slightly lightheaded; mild headache; This is a spontaneous report from a non-contactable nurse, the patient. A 54-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on an unknown date in Apr2021 at 08:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer with no recurrence. Concomitant medications included levothyroxine sodium (SYNTHYROID), omeprazole magnesium (PRILOSEC OTC), loratadine (CLARITIN), paracetamol (TYLENOL) and vitamin d nos (VIT D); all from an unknown date for an unknown indication. The patient previously took Influenza vaccine on unknown date in 2010 or 20211 and Zantac on unknown date; both for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 the patient experienced mild headache. On 02Apr2021 the patient experienced Slightly lightheaded. On 02Apr2021 at 13:00 the patient experienced GI symptoms started bloating and cramping led to profuse water diarrhea started in the evening and stopped around 8pm. On 02Apr2021 at 13:00 the patient experienced Intermittent weakness, feeling out of it, pain at injection site to shoulder up to left side of neck (no headache). On 02Apr2021 at 19:00 the patient experienced short of breath (had to rest to catch my breath) and had a catching cough, and feeling exhausted. Short of breath with a cough to Monday and then intermittent until Wednesday. Thurs and Fri starting to feel better but still have moments of weakness and a mild headache. On 05Apr2021, the patient underwent Nasal Swab and the result was Negative. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of the event Slightly lightheaded and GI symptoms started bloating and cramping led to profuse water diarrhea was recovered on 02Apr2021 and of the intermittent weakness, feeling out of it, pain at injection site to shoulder up to left side of neck, short of breath (had to rest to catch my breath), catching cough, feeling exhausted and mild headache was recovered with sequelae. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHYROID; OMEPRAZOLE MAGNESIUM; Claritin; TYLENOL; Vit d

Current Illness:

ID: 1534365
Sex: M
Age:
State: GA

Vax Date: 02/20/2021
Onset Date: 02/01/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: tired; headache; joint pain; couldnt lift my arm; This is a spontaneous report received from a contactable consumer (patient). This 63-year-old male patient received dose 1 of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number El9267) on 20Feb2021 at 11:00 as a single dose in the left arm for COVID-19 immunization. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included atorvastatin, metoprolol, and losartan from unknown dates for unknown indications. The patient previously received warfarin (COUMADIN) from an unknown date and experienced allergy. On an unspecified date the patient experienced joint pain severe for 14 days, tired for 14 days, headache for 14 days, and couldn't lift his arm for 3 days. The events were reported as non-serious. The patient was not hospitalized for the events. The outcomes of joint pain severe, tired, headache, and couldn't lift arm were unknown. It was also reported that since the vaccination the patient had not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2021400134 Same patient and drug, different dose/events

Other Meds: ATORVASTATIN; METOPROLOL; LOSARTAN

Current Illness:

ID: 1534366
Sex: M
Age:
State: GA

Vax Date: 03/10/2021
Onset Date: 03/17/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: 2 "DVTs" in left leg; 7 days later left leg and arm swelled up; inside left thigh very sore burns when I walk since the 17th of march; inside left thigh very sore; This is a spontaneous report received from a contactable consumer (patient). This 63-year-old male patient received dose 2 of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN6202) via an unspecified route of administration on 10Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunization. Medical history was none. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included atorvastatin, metoprolol, and losartan from unknown dates for unknown indications. The patient previously received warfarin (COUMADIN) from an unknown date and experienced allergy. The patient received dose 1 of bnt162b2 (lot number El9267) on 20Feb2021 at 11:00 as a single dose in the left arm for COVID-19 immunization and experienced joint pain severe 14 days, tired 14 days, headache 14 days, and couldn't lift his arm for 3 days. With dose 2 the patient had no pain, tiredness, or headache. Seven days later (on 17Mar2021) the patient experienced left leg and arm swelled up, had 2 "DVTS" in left leg. The swelling was down but inside left thigh was very sore and burned when he walked since 17Mar2021. The events were reported as non-serious. The patient was not hospitalized for the events. The patient visited a doctor or other healthcare professional office/clinic and emergency room./department or urgent care as a result of the events. The patient received treatment with rivaroxaban for clots. The outcomes of had 2 "DVTs," inside left thigh was very sore and burned when he walked were not recovered. The outcome of left leg and arm swelled up was recovering. It was also reported that since the vaccination the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021400070 Same patient and drug, different dose/events

Other Meds: ATORVASTATIN; METOPROLOL; LOSARTAN

Current Illness:

ID: 1534367
Sex: F
Age:
State:

Vax Date: 03/12/2021
Onset Date: 03/13/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Swollen lymph nodes on left side under arm and on top of my breast; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: El3302) via an unspecified route of administration in the left arm on 12Mar2021 at 11:45 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Mar2021, the patient experienced swollen lymph nodes on left side under arm and on top of the breast. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swollen lymph nodes on left side under arm and on top of the breast was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534368
Sex: F
Age:
State: NY

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: severe migraine; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 14:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine, asthma, chronic back pain, thyroid nodules, allergy to sulfa drugs and penicillin allergy. Concomitant medications included levocabastine hydrochloride (ZYRTEC), duloxetine hydrochloride (CYMBALTA), erenumab (AIMOVIG), trazodone hydrochloride (DEPRAX) and vitamin d (MANUFACTURER UNKNOWN); all from unknown start dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Mar2021 at 14:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation and also had known allergies to ibuprofen (MOTRIN), morphine (MANUFACTURER UNKNOWN) and oseltamivir phosphate (TAMIFLU). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 07Apr2021 at 14:30, the patient felt fine walking in to get vaccine but within minutes experienced a severe migraine. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severe migraine was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Zyrtec; CYMBALTA; AIMOVIG; Deprax; VITAMIN D NOS

Current Illness:

ID: 1534369
Sex: M
Age:
State: AL

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: "Uncontrollable shaking and tenseness"; "Uncontrollable shaking and tenseness"; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 08Apr2021 at 14:15 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included calcium carbonate, magnesium carbonate (TUMS) and paracetamol (TYLENOL). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 18Mar2021 at 14:15 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 07:00, the patient experienced uncontrollable shaking and tenseness and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with TYLENOL. The clinical outcome of the events "uncontrollable shaking and tenseness" and chills were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: Tums; TYLENOL

Current Illness:

ID: 1534370
Sex: F
Age:
State: TX

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Sore arm; Fatigue; Nausea; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Ew0151) via an unspecified route of administration on 08Apr2021 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome (IBS). The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced sore arm, fatigue, nausea and headache. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/ department or urgent care. The clinical outcome of the events sore arm, fatigue, nausea and headache was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1534371
Sex: F
Age:
State: GA

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Drowsiness; pain at the injection site; skin itching; slight neck pain; lightheaded; felt hot; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewolso) via an unspecified route of administration in the left arm on 07Apr2021 at 18:45 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included contact dermatitis, asthma, skin allergies hypothyroidism, depression, anxiety, year-round allergies and was allergic to gluten and soy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced drowsiness, pain at the injection site, skin itching, slight neck pain, lightheaded and felt hot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events drowsiness, pain at the injection site, skin itching, slight neck pain, lightheaded and felt hot was recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534372
Sex: F
Age:
State: PA

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Swollen ankles in the week following administration.; Disruptive headache in the 24 hours following administration.; This is a spontaneous report from a contactable consumer. An unspecified aged non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Apr2021 as a single dose for COVID-19 immunisation. Medical history included nephrectomy (1 kidney) and history of cancer. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown whether the patient had received any other vaccines within four weeks prior to the vaccination. On 04Apr2021, 24 hours following administration, the patient experienced disruptive headache and on 08Apr2021, swollen ankles in the week following administration. On an unknown date the patient underwent for unknown lab tests. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as the result of adverse events which included lab tests. The clinical outcome of disruptive headache and swollen ankles were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534373
Sex: F
Age:
State: HI

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Large red swollen splotch (hot and itchy) by injection 2 days later; Large red swollen splotch (hot and itchy) by injection 2 days later; Large red swollen splotch (hot and itchy) by injection 2 days later; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 07Apr2021 at 13:15 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and hypercortisolism. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was allergic to grass and shrimp. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 14Mar2021 at 10:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. On 09Apr2021 at 12:00, two days after the vaccination, the patient experienced large red swollen splotch (hot and itchy) by injection. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events large red swollen splotch (hot and itchy) was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534374
Sex: F
Age:
State: VT

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: left face cheek got tingly feeling; Left hand, left foot got tingly feeling; Very sore and throbbing arm where vaccine was/ forearm and top of hand had pain off and on all day; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 09:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the left arm on 16Mar2021 at 09:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 11:45, 2 hours after the vaccination, the patient left hand and left foot and left face cheek got a tingly feeling. Face tingling went away about 7 hours later. Hand and foot tingly next day. On the same day, the patient also experienced a very sore and throbbing arm where the vaccine was and the patient forearm and top of hand had pain off and on all day. The vaccine was taken on tuesday morning and by friday was pretty much gone. Just a little sore arm. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event face tingling resolved on 06Apr2021, after the duration of 7 hours. The clinical outcome of the event left hand and left foot tingly feeling was resolved on 07Apr2021. The clinical outcome of the event very sore and throbbing arm where the vaccine was/ forearm and top of hand had pain off and on all day was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534375
Sex: F
Age:
State: TX

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Painful left arm; Swelling and heat on left arm; Fatigue; Chills; Low grade fever; General malaise; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8737) via an unspecified route of administration in the left arm on 05Apr2021 at 11:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 06Apr2021, the patient experienced painful swelling and heat on left arm >2 days after injection, fatigue, chills, low grade fever and general malaise for at least 2 days (at the time of reporting). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event painful swelling and heat on left arm, fatigue, chills, low grade fever and general malaise was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534376
Sex: M
Age:
State: NY

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Golf ball sized bump at injection site; Soreness at injection site; red itchy rash at injection site; red itchy rash at injection site; red itchy rash at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 27Mar2021 at 08:15 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 06Mar2021 at 08:15 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 10:00, the patient experienced golf ball sized bump at injection site(vaccination site lump), red itchy rash at injection site and soreness at injection site. The patient did not receive any treatment for the reported events. The clinical outcome of the events bump at injection site, red itchy rash at injection site and soreness at injection site were recovered on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534377
Sex: F
Age:
State:

Vax Date: 02/17/2021
Onset Date: 02/19/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Heartburn; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 17Feb2021 at 13:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received penicillin (MANUFACTURER UNKNOWN) and ceftriaxone sodium (ROCEPHIN) for unknown indication and on unknown date and experienced drug allergy. Concomitant medications included birth Control (MANUFACTURER UNKNOWN) and daily multi-vitamin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021, the patient experienced heartburn. No therapeutic measures were taken as the result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event heartburn was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm